Carles Pericay Selected Research

Carles Pericay Research Topics

Disease

16	Neoplasms (Cancer) 10/2023 - 02/2010
15	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 01/2010
7	Adenocarcinoma 02/2024 - 10/2014
7	Rectal Neoplasms (Rectal Cancer) 12/2023 - 02/2010
5	Neoplasm Metastasis (Metastasis) 09/2021 - 10/2015
4	Disease Progression 09/2021 - 01/2010
4	Stomach Neoplasms (Stomach Cancer) 06/2018 - 08/2009
2	Diarrhea 10/2014 - 12/2013
1	Thrombocytopenia (Thrombopenia) 02/2024
1	Neutropenia 02/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024
1	Microsatellite Instability 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Surgical Wound Infection 01/2016
1	Anastomotic Leak 10/2014
1	Pulmonary Embolism 10/2014
1	Peritonitis 10/2014
1	Fatigue 12/2013
1	Breast Neoplasms (Breast Cancer) 04/2007
1	Pathologic Complete Response 04/2007

Drug/Important Bio-Agent (IBA)

10	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 02/2010
8	Capecitabine (Xeloda)FDA Link 12/2023 - 08/2009
7	Bevacizumab (Avastin)FDA Link 11/2020 - 01/2011
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2010
6	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 09/2012
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2013
5	Leucovorin (Folinic Acid)FDA Link 02/2024 - 12/2013
5	MicroRNAs (MicroRNA)IBA 06/2018 - 07/2013
4	Cetuximab (Erbitux)FDA Link 10/2015 - 01/2010
3	afliberceptIBA 12/2023 - 09/2015
3	ErbB Receptors (EGF Receptor)IBA 09/2023 - 04/2011
3	XELOXIBA 08/2020 - 01/2011
3	Panitumumab (Vectibix)FDA Link 01/2019 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 11/2019
2	trifluridine tipiracil drug combinationIBA 01/2022 - 09/2021
2	ParaffinIBA 10/2020 - 07/2013
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 08/2009
2	RNA (Ribonucleic Acid)IBA 01/2016 - 12/2015
1	Gemcitabine FDA Link 02/2024
1	130-nm albumin-bound paclitaxelIBA 02/2024
1	Alkaline PhosphataseIBA 09/2021
1	Circulating Tumor DNAIBA 01/2021
1	Trinitrotoluene (TNT)IBA 01/2021
1	Long Noncoding RNAIBA 10/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Circulating MicroRNAIBA 06/2018
1	RamucirumabIBA 12/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2016
1	Tryptophan (L-Tryptophan)FDA Link 01/2016
1	KynurenineIBA 01/2016
1	Monoclonal AntibodiesIBA 10/2015
1	Axitinib (AG 013736)IBA 12/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013
1	Formaldehyde (Formol)FDA Link 07/2013
1	Tumor Biomarkers (Tumor Markers)IBA 07/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 04/2011
1	Cisplatin (Platino)FDA LinkGeneric 08/2009
1	AnthracyclinesIBA 04/2007
1	Taxoids (Taxanes)IBA 04/2007
1	Estrogen ReceptorsIBA 04/2007
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2007

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 09/2023 - 04/2007
12	Therapeutics 04/2022 - 01/2011
5	Chemoradiotherapy 11/2020 - 02/2010
4	Neoadjuvant Therapy 12/2023 - 11/2019
4	Radiotherapy 12/2023 - 07/2020
2	Immunotherapy 08/2023 - 01/2020
2	Induction Chemotherapy 11/2019 - 01/2011
1	Metastasectomy 10/2023
1	Drug Tapering 09/2021
1	Salvage Therapy 01/2019
1	Conversion to Open Surgery 01/2016
1	Length of Stay 01/2016
1	Adjuvant Chemotherapy 02/2010